Case Report: A novel LHFPL3::NTRK2 fusion in dysembryoplastic neuroepithelial tumor

Neurotrophic tyrosine receptor kinase (NTRK) rearrangements are oncogenic drivers of various types of adult and pediatric tumors, including gliomas. However, NTRK rearrangements are extremely rare in glioneuronal tumors. Here, we report a novel NTRK2 rearrangement in a 24-year-old female with dysemb...

Full description

Bibliographic Details
Main Authors: Yanming Chen, Qing Zhu, Ye Wang, Xiaoxiao Dai, Ping Chen, Ailin Chen, Sujuan Zhou, Chungang Dai, Shengbin Zhao, Sheng Xiao, Qing Lan
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-12-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.1064817/full
_version_ 1811214245346410496
author Yanming Chen
Qing Zhu
Ye Wang
Xiaoxiao Dai
Ping Chen
Ailin Chen
Sujuan Zhou
Sujuan Zhou
Chungang Dai
Shengbin Zhao
Sheng Xiao
Qing Lan
author_facet Yanming Chen
Qing Zhu
Ye Wang
Xiaoxiao Dai
Ping Chen
Ailin Chen
Sujuan Zhou
Sujuan Zhou
Chungang Dai
Shengbin Zhao
Sheng Xiao
Qing Lan
author_sort Yanming Chen
collection DOAJ
description Neurotrophic tyrosine receptor kinase (NTRK) rearrangements are oncogenic drivers of various types of adult and pediatric tumors, including gliomas. However, NTRK rearrangements are extremely rare in glioneuronal tumors. Here, we report a novel NTRK2 rearrangement in a 24-year-old female with dysembryoplastic neuroepithelial tumor (DNT), a circumscribed WHO grade I benign tumor associated with epilepsy. By utilizing targeted RNA next-generation sequencing (NGS), fluorescence in situ hybridization (FISH), reverse transcriptase PCR (RT-PCR), and Sanger sequencing, we verified an in-frame fusion between NTRK2 and the lipoma HMGIC fusion partner-like 3 (LHFPL3). This oncogenic gene rearrangement involves 5’ LHFPL3 and 3’ NTRK2, retaining the entire tyrosine kinase domain of NTRK2 genes. Moreover, the targeted DNA NGS analysis revealed an IDH1 (p.R132H) mutation, a surprising finding in this type of tumor. The pathogenic mechanism of the LHFPL3::NTRK2 in this case likely involves aberrant dimerization and constitutive activation of RTK signaling pathways.
first_indexed 2024-04-12T06:01:15Z
format Article
id doaj.art-16584d7c9f904f249c1dc329500dc2db
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-04-12T06:01:15Z
publishDate 2022-12-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-16584d7c9f904f249c1dc329500dc2db2022-12-22T03:45:02ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2022-12-011210.3389/fonc.2022.10648171064817Case Report: A novel LHFPL3::NTRK2 fusion in dysembryoplastic neuroepithelial tumorYanming Chen0Qing Zhu1Ye Wang2Xiaoxiao Dai3Ping Chen4Ailin Chen5Sujuan Zhou6Sujuan Zhou7Chungang Dai8Shengbin Zhao9Sheng Xiao10Qing Lan11Department of Neurosurgery, The Second Affiliated Hospital of Soochow University, Suzhou, ChinaDepartment of Neurosurgery, The Second Affiliated Hospital of Soochow University, Suzhou, ChinaHeath Management Center, The Second Affiliated Hospital of Soochow University, Suzhou, ChinaDepartment of Pathology, The Second Affiliated Hospital of Soochow University, Suzhou, ChinaMolecular Genetics Laboratory, Suzhou Sano Precision Medicine Ltd., Suzhou, ChinaDepartment of Neurosurgery, The Second Affiliated Hospital of Soochow University, Suzhou, ChinaMolecular Genetics Laboratory, Suzhou Sano Precision Medicine Ltd., Suzhou, ChinaPathology and Pathophysiology, Soochow University Medical College, Suzhou, ChinaDepartment of Neurosurgery, The Second Affiliated Hospital of Soochow University, Suzhou, ChinaMolecular Genetics Laboratory, Suzhou Sano Precision Medicine Ltd., Suzhou, ChinaDepartment of Pathology, Brigham and Women’s Hospital, Boston, BS, United StatesDepartment of Neurosurgery, The Second Affiliated Hospital of Soochow University, Suzhou, ChinaNeurotrophic tyrosine receptor kinase (NTRK) rearrangements are oncogenic drivers of various types of adult and pediatric tumors, including gliomas. However, NTRK rearrangements are extremely rare in glioneuronal tumors. Here, we report a novel NTRK2 rearrangement in a 24-year-old female with dysembryoplastic neuroepithelial tumor (DNT), a circumscribed WHO grade I benign tumor associated with epilepsy. By utilizing targeted RNA next-generation sequencing (NGS), fluorescence in situ hybridization (FISH), reverse transcriptase PCR (RT-PCR), and Sanger sequencing, we verified an in-frame fusion between NTRK2 and the lipoma HMGIC fusion partner-like 3 (LHFPL3). This oncogenic gene rearrangement involves 5’ LHFPL3 and 3’ NTRK2, retaining the entire tyrosine kinase domain of NTRK2 genes. Moreover, the targeted DNA NGS analysis revealed an IDH1 (p.R132H) mutation, a surprising finding in this type of tumor. The pathogenic mechanism of the LHFPL3::NTRK2 in this case likely involves aberrant dimerization and constitutive activation of RTK signaling pathways.https://www.frontiersin.org/articles/10.3389/fonc.2022.1064817/fulldysembryoplastic neuroepithelial tumorsNTRK2LHFPL3next-generation sequencingIDH1
spellingShingle Yanming Chen
Qing Zhu
Ye Wang
Xiaoxiao Dai
Ping Chen
Ailin Chen
Sujuan Zhou
Sujuan Zhou
Chungang Dai
Shengbin Zhao
Sheng Xiao
Qing Lan
Case Report: A novel LHFPL3::NTRK2 fusion in dysembryoplastic neuroepithelial tumor
Frontiers in Oncology
dysembryoplastic neuroepithelial tumors
NTRK2
LHFPL3
next-generation sequencing
IDH1
title Case Report: A novel LHFPL3::NTRK2 fusion in dysembryoplastic neuroepithelial tumor
title_full Case Report: A novel LHFPL3::NTRK2 fusion in dysembryoplastic neuroepithelial tumor
title_fullStr Case Report: A novel LHFPL3::NTRK2 fusion in dysembryoplastic neuroepithelial tumor
title_full_unstemmed Case Report: A novel LHFPL3::NTRK2 fusion in dysembryoplastic neuroepithelial tumor
title_short Case Report: A novel LHFPL3::NTRK2 fusion in dysembryoplastic neuroepithelial tumor
title_sort case report a novel lhfpl3 ntrk2 fusion in dysembryoplastic neuroepithelial tumor
topic dysembryoplastic neuroepithelial tumors
NTRK2
LHFPL3
next-generation sequencing
IDH1
url https://www.frontiersin.org/articles/10.3389/fonc.2022.1064817/full
work_keys_str_mv AT yanmingchen casereportanovellhfpl3ntrk2fusionindysembryoplasticneuroepithelialtumor
AT qingzhu casereportanovellhfpl3ntrk2fusionindysembryoplasticneuroepithelialtumor
AT yewang casereportanovellhfpl3ntrk2fusionindysembryoplasticneuroepithelialtumor
AT xiaoxiaodai casereportanovellhfpl3ntrk2fusionindysembryoplasticneuroepithelialtumor
AT pingchen casereportanovellhfpl3ntrk2fusionindysembryoplasticneuroepithelialtumor
AT ailinchen casereportanovellhfpl3ntrk2fusionindysembryoplasticneuroepithelialtumor
AT sujuanzhou casereportanovellhfpl3ntrk2fusionindysembryoplasticneuroepithelialtumor
AT sujuanzhou casereportanovellhfpl3ntrk2fusionindysembryoplasticneuroepithelialtumor
AT chungangdai casereportanovellhfpl3ntrk2fusionindysembryoplasticneuroepithelialtumor
AT shengbinzhao casereportanovellhfpl3ntrk2fusionindysembryoplasticneuroepithelialtumor
AT shengxiao casereportanovellhfpl3ntrk2fusionindysembryoplasticneuroepithelialtumor
AT qinglan casereportanovellhfpl3ntrk2fusionindysembryoplasticneuroepithelialtumor